Syneron Medical Ltd. (
Q2 2011 Earnings Call
August 11, 2011, 11:00 am ET
Zack Kubow - Ruth Group
Lou Scafuri - CEO
Asaf Alperovitz - CFO
Richard Newitter - Leerink Swann
Amit Hazan - Gleacher & Company
Anthony Vendetti - Maxim Group
Dalton Chamber - Needham & Company
Good day ladies and gentlemen and welcome to the Syneron Medical Limited second quarter 2011 results conference call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn your conference over to your host for today, Mr. Zack Kubow of the Ruth Group. Sir, you may begin.
Thank you, operator. I’d like to welcome you to Syneron Medical’s Second Quarter 2011 conference call.
Statements on this call may be forward-looking within the meaning of the US Private Securities Litigation Reform Act of 1995 relating to the company’s future events or future performance, including statements with respect to Syneron’s expectations regarding, but not limited to the financial forecast for 2011, the launch of new products and the maintenance of a leadership position in core and non-core markets.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the company’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in any forward-looking statements.